Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Chan

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Urology|December 1, 1996
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancerJ D Pearson, A A Luderer, E J Metter, et al.
Urology|June 7, 2000
Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assaysR L Vessella, P H Lange, A W Partin, et al.
The Prostate|July 1, 1995
Longitudinal evaluation of serum androgen levels in men with and without prostate cancerH B Carter, J D Pearson, E J Metter, et al.
The Journal of Urology|November 17, 1998
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findingsJ I Epstein, D W Chan, L J Sokoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III diseaseD W Chan, R A Beveridge, H Muss, et al.
Urology|April 18, 2001
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancerM Han, S Piantadosi, M L Zahurak, et al.
Clinical Chemistry|December 4, 1998
Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA 125H E van Ingen, D W Chan, W Hubl, et al.
British Journal of Cancer|July 25, 2013
The interaction between C35 and ΔNp73 promotes chemo-resistance in ovarian cancer cellsT H-Y Leung, S C-S Wong, K K-L Chan, et al.
JAMA|April 22, 1992
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseH B Carter, J D Pearson, E J Metter, et al.
Urology|March 1, 1997
Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisH B Carter, A W Partin, A A Luderer, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Urology|December 1, 1996
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancerJ D Pearson, A A Luderer, E J Metter, et al.
Urology|June 7, 2000
Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assaysR L Vessella, P H Lange, A W Partin, et al.
The Prostate|July 1, 1995
Longitudinal evaluation of serum androgen levels in men with and without prostate cancerH B Carter, J D Pearson, E J Metter, et al.
The Journal of Urology|November 17, 1998
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findingsJ I Epstein, D W Chan, L J Sokoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III diseaseD W Chan, R A Beveridge, H Muss, et al.
Urology|April 18, 2001
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancerM Han, S Piantadosi, M L Zahurak, et al.
Clinical Chemistry|December 4, 1998
Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA 125H E van Ingen, D W Chan, W Hubl, et al.
British Journal of Cancer|July 25, 2013
The interaction between C35 and ΔNp73 promotes chemo-resistance in ovarian cancer cellsT H-Y Leung, S C-S Wong, K K-L Chan, et al.
JAMA|April 22, 1992
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseH B Carter, J D Pearson, E J Metter, et al.
Urology|March 1, 1997
Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisH B Carter, A W Partin, A A Luderer, et al.
Pageof 17